HLA phenotypes of ESRD patients are risk factors in the panel-reactive antibody (PRA) response

Clinical Transplantation

Volumn 15, Issue SUPPL. 6, 2001, Pages 22-27

  Heise, E ^a   Manning, C ^a   Thacker, L ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b South Eastern Organ Procurement Foundation   (United States)

Author keywords

HLA phenotype; Immune response regulation; Kidney transplantation; Panel reactive antibody; Recipient sensitization

Indexed keywords

ALLOANTIBODY; HLA A1 ANTIGEN; HLA A3 ANTIGEN; HLA ANTIGEN CLASS 2; HLA B35 ANTIGEN; HLA B8 ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR6 ANTIGEN; HLA DR7 ANTIGEN;

ADULT; AGE; ANALYSIS; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; CADAVER DONOR; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; COVARIANCE; ETHNOLOGY; FEMALE; GENDER; GENE CONTROL; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; GRAFT SURVIVAL; HAPLOTYPE; HELPER CELL; HLA SYSTEM; HUMAN; IMMUNE RESPONSE GENE; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MODULATION; MULTIVARIATE ANALYSIS; ORGAN TRANSPLANTATION; ORGANIZATION; PHENOTYPE; PREDICTION; PREGNANCY; PRIORITY JOURNAL; RECIPIENT; REGRESSION ANALYSIS; RISK FACTOR; SENSITIZATION; STATISTICAL ANALYSIS; TRANSFUSION; UNITED STATES;

EID: 0035172072     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2001.00004.x     Document Type: Article

References (31)

1. Sensitization in renal transplantation
2. Risk factors for renal allograft survival from older cadaver donor
3. Postoperative production of anti-donor antibody and chronic rejection in renal transplantation
4. Effect of recipient sensitization (peak PRA) on graft outcome in haplo-identical living related kidney transplants
5. Should I accept this kidney?
6. HLA compatibility and organ transplant survival
7. Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigens
8. Indirect recognition of donor HLA-DR peptides in organ allograft rejection
9. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction
10. The estimation and significance of the logarithm of a ratio of frequencies
11. On estimating the relation between blood group and disease
12. Multiple comparisons among means
13. Reference tables of three locus haplotype frequencies and delta values
14. Population analysis of HLA-A, -B, -DR and other genetic markers. Histocompatibility testing
15. The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder
16. HLA phenotype that may be associated with absence of allosensitization in candidates for cadaver donor kidney allografts
17. HLA-DR1 is a low responsiveness antigen in human kidney transplant recipients
18. HLA-DR1 Recipients have the highest kidney transplant survival
19. Individualization of high and low-risk HLA-DR incompatibilities in renal transplantation
20. HLA-DR2, a marker for class I antigen sensitization
21. Influence of DR specificity and major histocompatibility complex matching on cadaveric kidney graft survival
22. The regulatory role of HLA-DR6 in renal transplantation
23. HLA-DR3 is a marker of graft failure in cadaveric renal transplantation
24. HLA-DR3 associated with improved kidney transplant survival
25. Beneficial effects of HLA-DR3 gene expression on renal allograft survival
26. Recipients HLA-DR pehnotype and renal outcome
27. Are cyclosporine-treated HLA-DRw6-positive cadaveric kidney allograft recipients high responders?
28. HLA-DRw6 and renal allograft rejection
29. Estimation of HLA-R, -B, -DR haplotype frequencies in five racial groups represented in the NMDP donor file